Science Explorer Back to mapMap

Most cited papers from Cubist Pharmaceuticals (United States)

What are the most cited papers from Cubist Pharmaceuticals (United States)?

The most cited paper from Cubist Pharmaceuticals (United States) is "Biofilms: the matrix revisited" (Steven S. Branda, Åshild Vik, Lisa Friedman et al., 2004), with 1,821 citations. Next come "Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by Staphylococcus aureus" (1,472) and "Tackling antibiotic resistance" (1,077).

Showing 50 of 60 papers. Every paper with more than 163 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Biofilms: the matrix revisited Steven S. Branda, Åshild Vik, Lisa Friedman et al. · Trends in Microbiology Review 10 Dec 2004 1,821
2 Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by Staphylococcus aureus Vance G. Fowler et al. · New England Journal of Medicine Open access 16 Aug 2006 1,472
3 Tackling antibiotic resistance Karen Bush et al. · Nature Reviews Microbiology Open access 2 Nov 2011 1,077
4 The Safety and Efficacy of Daptomycin for the Treatment of Complicated Skin and Skin-Structure Infections Robert D. Arbeit, Dennis G. Maki, Frank Tally et al. · Clinical Infectious Diseases 2 Jun 2004 697
5 Correlation of Daptomycin Bactericidal Activity and Membrane Depolarization in Staphylococcus aureus Jared A. Silverman, Nancy G. Perlmutter, Howard M. Shapiro · Antimicrobial Agents and Chemotherapy Open access 23 Jul 2003 662
6 Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections Judith N. Steenbergen, Jeff D. Alder, Grace M. Thorne et al. · Journal of Antimicrobial Chemotherapy 10 Feb 2005 568
7 Inhibition of Daptomycin by Pulmonary Surfactant: In Vitro Modeling and Clinical Impact Jared A. Silverman, Lawrence I. Mortin, Andrew D. G. VanPraagh et al. · The Journal of Infectious Diseases 20 May 2005 543
8 Renaissance in antibacterial discovery from actinomycetes Richard H. Baltz · Current Opinion in Pharmacology 4 Jun 2008 506
9 Antibiotic Susceptibility Profiles of Escherichia coli Strains Lacking Multidrug Efflux Pump Genes Mark C. Sulavik, Chad Houseweart, Christina Cramer et al. · Antimicrobial Agents and Chemotherapy Open access Apr 2001 503
10 Delirium duration and mortality in lightly sedated, mechanically ventilated intensive care patients* Yahya Shehabi, Richard R. Riker, Paula M. Bokesch et al. · Critical Care Medicine 10 Sep 2010 477
11 Genetic Changes That Correlate with Reduced Susceptibility to Daptomycin in Staphylococcus aureus Lisa Friedman, Jeff D. Alder, Jared A. Silverman · Antimicrobial Agents and Chemotherapy 24 May 2006 457
12 Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001 05 Gregory E. Steinkraus, Roger L. White, Lawrence V. Friedrich · Journal of Antimicrobial Chemotherapy 10 Jul 2007 424
13 Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECT-cIAI) Joseph S. Solomkin, Ellie Hershberger, Benjamin W. Miller et al. · Clinical Infectious Diseases Open access 10 Feb 2015 419
14 The value of natural products to future pharmaceutical discovery Dwight D. Baker, Min Chu, Uma Oza et al. · Natural Product Reports 2007 417
15 Natural products to drugs: daptomycin and related lipopeptide antibiotics Richard H. Baltz, Vivian Miao, Stephen K. Wrigley · Natural Product Reports 2005 398
16 Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI) Florian Wagenlehner, Obiamiwe Umeh, Judith N. Steenbergen et al. · The Lancet 28 Apr 2015 387
17 Daptomycin biosynthesis in Streptomyces roseosporus: cloning and analysis of the gene cluster and revision of peptide stereochemistry Vivian Miao, Marie-Françoise Coëffet-LeGal, Paul Brian et al. · Microbiology May 2005 369
18 Daptomycin Pharmacokinetics and Safety following Administration of Escalating Doses Once Daily to Healthy Subjects Barry H. Dvorchik, D J Brazier, Michael F. DeBruin et al. · Antimicrobial Agents and Chemotherapy Open access 24 Mar 2003 361
19 Clinical and economic consequences of hospital-acquired resistant and multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis Dilip Nathwani, Gowri Raman, Katherine A. Sulham et al. · Antimicrobial Resistance and Infection Control ReviewOpen access 20 Oct 2014 353
20 Effects of control interventions on Clostridium difficile infection in England: an observational study Kate E. Dingle et al. · The Lancet Infectious Diseases Open access 24 Jan 2017 330
21 Daptomycin-Mediated Reorganization of Membrane Architecture Causes Mislocalization of Essential Cell Division Proteins Joe Pogliano, N. Pogliano, Jared A. Silverman · Journal of Bacteriology Open access Jun 2012 326
22 Pharmacokinetics and Tolerability of Daptomycin at Doses up to 12 Milligrams per Kilogram of Body Weight Once Daily in Healthy Volunteers Mark S. Benvenuto, David P. Benziger, Sara Yankelev et al. · Antimicrobial Agents and Chemotherapy Open access 27 Sep 2006 325
23 Development of daptomycin for Gram-positive infections Francis P. Tally, Michael F. DeBruin · Journal of Antimicrobial Chemotherapy Oct 2000 322
24 Selective Postoperative Inhibition of Gastrointestinal Opioid Receptors Akiko Taguchi, Neeru Sharma, Rao M. Saleem et al. · New England Journal of Medicine Open access 27 Sep 2001 321
25 Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial Gregory J. Moran, Edward Fang, G. Ralph Corey et al. · The Lancet Infectious Diseases 5 Jun 2014 309
26 Revised guides for organ sampling and trimming in rats and mice – Part 1 Christine Ruehl-Fehlert, Birgit Kittel, Gerd Morawietz et al. · Experimental and Toxicologic Pathology 2003 306
27 Alvimopan, a Novel, Peripherally Acting μ Opioid Antagonist Bruce G. Wolff, Fabrizio Michelassi, Todd M. Gerkin et al. · Annals of Surgery Open access 21 Sep 2004 301
28 Combinatorial biosynthesis of novel antibiotics related to daptomycin Kien Trung Nguyen, Daniel Ritz, Jian-Qiao Gu et al. · Proceedings of the National Academy of Sciences Open access 7 Nov 2006 291
29 Incidence of Herpes Zoster, Before and After Varicella‐Vaccination–Associated Decreases in the Incidence of Varicella, 1992–2002 Aisha Obad Jumaan, Onchee Yu, Lisa A. Jackson et al. · The Journal of Infectious Diseases Open access 20 May 2005 286
30 Bactericidal Action of Daptomycin against Stationary-Phase and Nondividing Staphylococcus aureus Cells Carmela T. M. Mascio, Jeff D. Alder, Jared A. Silverman · Antimicrobial Agents and Chemotherapy Open access 9 Oct 2007 279
31 An international multicenter retrospective study of Pseudomonas aeruginosa nosocomial pneumonia: impact of multidrug resistance Scott T. Micek, Richard G. Wunderink, Marin H. Kollef et al. · Critical Care Open access 30 Apr 2015 277
32 Daptomycin: mechanisms of action and resistance, and biosynthetic engineering Richard H. Baltz · Current Opinion in Chemical Biology Review 20 Mar 2009 268
33 Structural Basis for Double-Sieve Discrimination of L-Valine from L-Isoleucine and L-Threonine by the Complex of tRNAVal and Valyl-tRNA Synthetase Shuya Fukai, Osamu Nureki, Shun‐ichi Sekine et al. · Cell Open access Nov 2000 268
34 Induction of Daptomycin Heterogeneous Susceptibility in Staphylococcus aureus by Exposure to Vancomycin George Sakoulas, Jeff D. Alder, Claudie Thauvin-Eliopoulos et al. · Antimicrobial Agents and Chemotherapy Open access 28 Mar 2006 263
35 Comprehensive Survey of Combinatorial Library Synthesis: 2000 Roland E. Dolle · Journal of Combinatorial Chemistry 6 Oct 2001 257
36 Epidemiology of Clostridium difficile Infection Daryl D. DePestel, David Michael Aronoff · Journal of Pharmacy Practice Open access 24 Sep 2013 252
37 Comprehensive Survey of Combinatorial Library Synthesis: 2005 Roland E. Dolle, Bertrand Le Bourdonnec, Guillermo A. Morales et al. · Journal of Combinatorial Chemistry 23 Aug 2006 250
38 Marcel Faber Roundtable: Is our antibiotic pipeline unproductive because of starvation, constipation or lack of inspiration? Richard H. Baltz · Journal of Industrial Microbiology & Biotechnology 17 Jan 2006 248
39 Whole Genome Characterization of the Mechanisms of Daptomycin Resistance in Clinical and Laboratory Derived Isolates of Staphylococcus aureus Anton Yariv Peleg, Spiros Miyakis, Doyle V. Ward et al. · PLoS ONE Open access 6 Jan 2012 245
40 Resistance Studies with Daptomycin Jared A. Silverman, N. Oliver, Ted Andrew et al. · Antimicrobial Agents and Chemotherapy Open access Jun 2001 235
41 Drug discovery from natural products Vincent P. Gullo, James B. McAlpine, Kin S. Lam et al. · Journal of Industrial Microbiology & Biotechnology Open access 16 Mar 2006 224
42 Analysis of Cell Membrane Characteristics of In Vitro-Selected Daptomycin-Resistant Strains of Methicillin-Resistant Staphylococcus aureus Nagendra Nath Mishra, Soo‐Jin Yang, Ayumi Sawa et al. · Antimicrobial Agents and Chemotherapy Open access 31 Mar 2009 223
43 Phase III Trial of Alvimopan, a Novel, Peripherally Acting, Mu Opioid Antagonist, for Postoperative Ileus After Major Abdominal Surgery Conor Patrick Delaney, James Leighton Weese, Neil Hyman et al. · Diseases of the Colon & Rectum 19 May 2005 220
44 Hippocampal Expression Analyses Reveal Selective Association of Immediate-Early, Neuroenergetic, and Myelinogenic Pathways with Cognitive Impairment in Aged Rats Wayne B. Rowe, Eric M. Blalock, Kuey-Chu Chen et al. · Journal of Neuroscience Open access 21 Mar 2007 218
45 Retrohoming of a Bacterial Group II Intron Benoit Cousineau, Dorie Smith, Stacey Lawrence-Cavanagh et al. · Cell Open access Aug 1998 218
46 The Importance of Bactericidal Drugs: Future Directions in Infectious Disease Robert W. Finberg, Robert C. Moellering, Francis P. Tally et al. · Clinical Infectious Diseases Open access 15 Oct 2004 216
47 Alvimopan Accelerates Gastrointestinal Recovery After Radical Cystectomy: A Multicenter Randomized Placebo-Controlled Trial Cheryl T. Lee, Sam S. Chang, Ashish M. Kamat et al. · European Urology 26 Feb 2014 215
48 Transcriptional Profiling Reveals that Daptomycin Induces the Staphylococcus aureus Cell Wall Stress Stimulon and Genes Responsive to Membrane Depolarization Arunachalam Muthaiyan, Jared A. Silverman, Radheshyam K. Jayaswal et al. · Antimicrobial Agents and Chemotherapy Open access 17 Dec 2007 208
49 Daptomycin: a novel agent for Gram-positive infections Francis P. Tally, Michael L. Zeckel, Margaret M. Wasilewski et al. · Expert Opinion on Investigational Drugs Aug 1999 207
50 Genetic Basis for Daptomycin Resistance in Enterococci Kelli L. Palmer, Anu Daniel, Crystal Hardy et al. · Antimicrobial Agents and Chemotherapy Open access 19 Apr 2011 200

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.